Pictet Asset Management (Switzerland)’s United Therapeutics UTHR Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$38M	Sell	172,301 -116,117	-40%	-$25.7M	0.05%	340
2023 Q1	$64.6M	Buy	288,418 +3,766	+1%	+$928K	0.08%	254
2022 Q4	$79.2M	Sell	284,652 -103,256	-27%	-$26.1M	0.11%	214
2022 Q3	$81.2M	Sell	387,908 -186,603	-32%	-$41.7M	0.12%	209
2022 Q2	$135M	Sell	574,511 -68,063	-11%	-$13.8M	0.19%	156
2022 Q1	$115M	Buy	642,574 +103,805	+19%	+$19.8M	0.13%	201
2021 Q4	$116M	Buy	538,769 +253,350	+89%	+$49.7M	0.12%	210
2021 Q3	$52.7M	Buy	+285,419	New	+$56.2M	0.06%	328

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s UTHR Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its United Therapeutics (UTHR) stake by 40% in Q2 2023, selling an estimated $25.7M and leaving 172,301 shares worth $38M. The position accounts for 0.05% of the portfolio, ranked #340.

Pictet Asset Management (Switzerland) first reported a position in UTHR in Q3 2021 and has held it in 8 quarters since. The position peaked at $135M in Q2 2022. 475 funds tracked by Wall St. Rank hold UTHR as of Q2 2023.

Pictet Asset Management (Switzerland) held 172,301 shares of United Therapeutics worth $38M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 116,117 United Therapeutics shares in Q2 2023, an estimated $25.7M.
United Therapeutics made up 0.05% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #340 holding.
Pictet Asset Management (Switzerland) first reported a position in United Therapeutics in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s United Therapeutics position peaked at $135M in Q2 2022.
475 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.